Joe955685 · Newsroom

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis
Despite mammalian cell cultures being the preferred manufacturing approach for biologics

January 21, 2021